Firoozeh Sahebi Selected Research

Firoozeh Sahebi Research Topics

19	Multiple Myeloma 03/2024 - 11/2003
6	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2021 - 11/2003
5	Neoplasms (Cancer) 12/2021 - 07/2004
4	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 08/2002
3	Hodgkin Disease (Hodgkin's Disease) 01/2023 - 12/2015
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 03/2012
2	Leukemia 04/2017 - 06/2010
2	Disease Progression 03/2012 - 12/2011
2	Primary Myelofibrosis (Myelosclerosis) 02/2010 - 11/2006
1	Neutropenia 01/2023
1	Bacteremia 12/2021
1	Rheumatoid Arthritis 01/2020
1	Pathologic Complete Response 12/2015
1	Skin Neoplasms (Skin Cancer) 02/2013
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2011
1	Enteritis 01/2011
1	T-Cell Lymphoma (Lymphoma, T Cell) 07/2010
1	Lymphoma (Lymphomas) 07/2010
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2010
1	Infections 04/2009
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2008
1	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2005
1	Bronchiolitis Obliterans Syndrome 04/2005
1	Acute Kidney Injury (Acute Renal Failure) 07/2004

6	fludarabineIBA 03/2024 - 11/2008
3	Melphalan (Alkeran)FDA LinkGeneric 03/2024 - 01/2019
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 10/2005
2	Bortezomib (Velcade)FDA Link 03/2024 - 03/2012
2	Brentuximab VedotinIBA 01/2023 - 12/2015
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 02/2010
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 04/2005
2	Lenalidomide (CC 5013)FDA Link 07/2018 - 02/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2018 - 03/2012
2	Etoposide (VP 16)FDA LinkGeneric 04/2017 - 10/2005
2	trans-crotonin (CTN)IBA 01/2017 - 12/2011
2	Tacrolimus (Prograf)FDA LinkGeneric 02/2010 - 04/2005
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2006 - 04/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	NivolumabIBA 01/2023
1	Drug CombinationsIBA 01/2023
1	AntigensIBA 12/2021
1	Clofarabine (Clolar)FDA Link 01/2021
1	Calcineurin InhibitorsIBA 01/2021
1	daratumumabIBA 10/2020
1	Metformin (Glucophage)FDA LinkGeneric 10/2020
1	Ritonavir (Norvir)FDA Link 10/2020
1	Leflunomide (Arava)FDA LinkGeneric 01/2020
1	Proteasome InhibitorsIBA 01/2019
1	Immunomodulating AgentsIBA 01/2019
1	pomalidomideIBA 07/2018
1	ixazomibIBA 07/2018
1	Dihydrotachysterol (AT 10)IBA 02/2013
1	Thalidomide (Thalomid)FDA Link 03/2012
1	Methotrexate (Mexate)FDA LinkGeneric 11/2006
1	ibritumomab tiuxetan (Zevalin)FDA Link 10/2005
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2005
1	Prednisone (Sone)FDA LinkGeneric 04/2005

16	Cell Transplantation 12/2021 - 11/2003
7	Stem Cell Transplantation 01/2023 - 10/2005
6	Therapeutics 01/2023 - 11/2003
3	Hematopoietic Stem Cell Transplantation 03/2024 - 08/2002
3	Autologous Transplantation 01/2022 - 12/2015
3	Transplantation 12/2021 - 11/2003
3	Homologous Transplantation 01/2013 - 11/2003
2	Salvage Therapy 12/2021 - 04/2005
1	Immunotherapy 01/2023
1	Catheters 12/2021
1	Radioimmunotherapy 12/2021
1	Haploidentical Transplantation 01/2019
1	Lymphatic Irradiation 04/2017
1	Combination Drug Therapy (Combination Chemotherapy) 12/2015
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2012
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2011
1	Chemoradiotherapy 07/2004
1	Contraindications 08/2002